Compliance Updates for PBMs and TPAs

This session will provide an overview of the latest federal and state regulatory developments affecting the commercial prescription drug market and their impact on both PBMs and TPAs. Attendees will gain insight into how new laws and enforcement actions are reshaping pricing transparency, reimbursement models, and operational requirements. The discussion will also highlight evolving compliance expectations for health plans, including oversight responsibilities, vendor governance, audit rights, and risk management when working with PBMs in today’s increasingly complex regulatory environment.